CEO thinks it will replace the current test in the UK "quite rapidly"....
http://www.brr.com.au/event/63112/spire-healthcare-agrees-commercial-terms-with-healthlinx-uk-distributor-intus-healthcare-to-process-and-market-ovplex-nick-gatsios-managing-director
Also, note that the market in the UK is 750,000 test, but the US is 8 Million tests.